361 Capital’s Bio-Techne TECH Stock Holding History

361 Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-22,872	Closed	-$864K	–	391
2018 Q1	$864K	Buy	+22,872	New	+$808K	0.21%	221

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

361 Capital's TECH Position: Q2 2018 in Review

361 Capital sold out of Bio-Techne (TECH) in Q2 2018, closing a stake of 22,872 shares — an estimated $864K sold.

361 Capital first reported a position in TECH in Q1 2018 and held it in 1 quarter. The position peaked at $864K in Q1 2018. 341 funds tracked by Wall St. Rank hold TECH as of Q2 2018.

361 Capital reported no remaining Bio-Techne position as of Q2 2018 after selling out during the quarter.
361 Capital sold 22,872 Bio-Techne shares in Q2 2018, an estimated $864K.
361 Capital first reported a position in Bio-Techne in Q1 2018 and held it in 1 quarter.
361 Capital's Bio-Techne position peaked at $864K in Q1 2018.
341 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2018.

Based on 361 Capital's 13F filing for Q2 2018, filed 14 Aug 2018.